Zobrazeno 1 - 10
of 15
pro vyhledávání: '"I. N. Trofimenko"'
Publikováno v:
Современная ревматология, Vol 17, Iss 3, Pp 71-75 (2023)
Obliterative (constrictive) bronchiolitis (OB) is a rare disease characterized by destruction of the bronchiolar epithelium and subsequent progressive airway obstruction. OB is most common in rheumatoid arthritis (RA) compared to other systemic rheum
Externí odkaz:
https://doaj.org/article/5d6b3b9e31f742e0b526979daf7289d2
Autor:
I. N. Trofimenko, B. A. Chernyak
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 108-115 (2020)
Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) are chronic inflammatory diseases of the airways. Inhaled bronchodilators and corticosteroids are the cornerstone of pharmacological long-term treatment for asthma and COPD. The e
Externí odkaz:
https://doaj.org/article/4afe90d08e4541e0bf83f4e16aaa4364
Publikováno v:
Медицинский совет, Vol 0, Iss 18, Pp 8-12 (2017)
Bronchial hyperreactivity (BHR) is one of the functional characteristics of chronic obstructive pulmonary disease (COPD) and is present in most patients with this disease. BHR has a negative modifying effect on the development of COPD, contributing t
Externí odkaz:
https://doaj.org/article/2ce0ab481da8426b928e17a38c45efd5
Autor:
I. N. Trofimenko, B. A. Chernyak
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 8-13 (2015)
The article tells about the results of evaluating the effects of tiotropium on the level of bronchial hyperresponsiveness (BHR) and comparing its clinical efficacy in patients with chronic obstructive pulmonary disease (COPD) depending on the level o
Externí odkaz:
https://doaj.org/article/8bb79cf76b6d4459996ba738b9018b3c
Autor:
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, A. A. Vizel, I. V. Demko, A. V. Emelyanov, A. A. Zaycev, G. L. Ignatova, N. P. Kniajeskaia, L. M. Kudelya, I. V. Leshchenko, S. I. Ovcharenko, A. I. Sinopalnikov, I. N. Trofimenko, V. D. Fedotov, R. F. Khamitov
Publikováno v:
PULMONOLOGIYA. 33:109-118
Chronic obstructive pulmonary disease (COPD) is a progressing disease. Each exacerbation impairs the patient’s prognosis and increases burden for the healthcare system. The most common maintenance treatment options for COPD include long-acting bron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5704e94708cbb7c319d471536942f02
https://doi.org/10.18093/0869-0189-202333-1-109-118
https://doi.org/10.18093/0869-0189-202333-1-109-118
Autor:
S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, M. M. Ilkovich, E. A. Kogan, Z. M. Merzhoeva, D. V. Petrov, M. V. Samsonova, S. A. Terpigorev, N. V. Trushenko, I. N. Trofimenko, I. E. Tyurin, A. L. Chernyaev, B. A. Chernyak, A. V. Chernyak, S. Yu. Chikina, A. G. Chuchalin, E. I. Shmelev
Publikováno v:
PULMONOLOGIYA. 32:473-495
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic fibrotic interstitial pneumonia with a progressive course and poor prognosis. The prevalence of IPF in the Russian Federation is about 8 – 12 cases per 100,000 population. The basic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caf8a53a6bb4fdb71a1604d2445a3714
https://doi.org/10.18093/0869-0189-2022-32-3-473-495
https://doi.org/10.18093/0869-0189-2022-32-3-473-495
Publikováno v:
PULMONOLOGIYA. 32:199-207
The Interstitial lung diseases (ILD) are a wide heterogeneous group of disorders, different in many parameters, however having similar pathophysiological mechanisms. Idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia (NSIP), chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5350f5b8725d8905c4ae8f74ed1eb6cf
https://doi.org/10.18093/0869-0189-2022-32-2-199-207
https://doi.org/10.18093/0869-0189-2022-32-2-199-207
Autor:
E. I. Shmelev, Zaurbek Aisanov, G. L. Ignatova, Andrey Belevskiy, Svetlana Ovcharenko, I. N. Trofimenko, V. V. Arkhipov, Sergey Avdeev, Igor Leshchenko, I. V. Demko, A. V. Emel'yanov
Publikováno v:
Russian Pulmonology. 30:330-343
The main objectives of chronic obstructive pulmonary disease (COPD) therapy are to reduce the severity of symptoms and the risk of exacerbations. The article discusses the role of local and systemic inflammation in the pathogenesis of COPD as well as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::472903fe03dd8e39aaffc1b68f725560
https://doi.org/10.18093/0869-0189-2020-30-3-330-343
https://doi.org/10.18093/0869-0189-2020-30-3-330-343
Autor:
Ch. Ch. Mandarzhap, L. M. Kudelya, Elena Sobko, I. A. Soloveva, Irina Demko, N. S. Gyrgeshkinova, N. G. Ganyukova, A. V. Tetenevа, I. N. Trofimenko, A. A. Grebenyuk, S. A. Luk'yanov, O. A. Meshcheryakova
Publikováno v:
Russian Pulmonology. 30:245-251
Chronic obstructive pulmonary disease (COPD) is a global problem in modern medicine. In recent years, the medical community’s understanding of COPD has changed significantly, which is primarily due to the emergence of a new classification and the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12a6b377f3b765e897b72b75e01a7300
https://doi.org/10.18093/0869-0189-2020-30-2-245-251
https://doi.org/10.18093/0869-0189-2020-30-2-245-251
Autor:
I. N. Trofimenko, B. A. Chernyak
Publikováno v:
PULMONOLOGIYA. :86-91
The efficacy of salmeterol/fluticasone propionate (S / FP) (Seretid, GlaxoSmithKline) was studied in a randomized open comparative trial in parallel groups. The study involved 36 patients with severe COPD (GOLD, 2003). The 1st group patients (n = 18)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a25f83608beb2466877937716f30f62
https://doi.org/10.18093/0869-0189-2005-0-4-86-91
https://doi.org/10.18093/0869-0189-2005-0-4-86-91